7Baggers

Fulgent Genetics Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 -151.12-78.19-5.2567.69140.62213.56286.49359.43Milllion

Fulgent Genetics Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 
                                      
  revenue81,803,000 73,463,000 76,214,000 71,743,000 71,028,000 64,485,000 70,505,000 84,687,000 67,853,000 66,168,000 67,704,000 105,655,000 125,341,000 320,268,000 251,671,000 227,868,000 153,616,000 359,429,000 294,978,000 101,716,000 17,265,000 7,753,000 8,387,000 10,347,000 8,424,000 5,370,000 5,673,000 5,625,000 5,400,000 4,653,000 4,281,000 4,503,000 4,640,000 5,306,000 5,854,000 5,011,000 
  yoy15.17% 13.92% 8.10% -15.28% 4.68% -2.54% 4.14% -19.85% -45.87% -79.34% -73.10% -53.63% -18.41% -10.90% -14.68% 124.02% 789.75% 4536.00% 3417.09% 883.05% 104.95% 44.38% 47.84% 83.95% 56.00% 15.41% 32.52% 24.92% 16.38% -12.31% -26.87% -10.14%     
  qoq11.35% -3.61% 6.23% 1.01% 10.15% -8.54% -16.75% 24.81% 2.55% -2.27% -35.92% -15.71% -60.86% 27.26% 10.45% 48.34% -57.26% 21.85% 190.00% 489.15% 122.69% -7.56% -18.94% 22.83% 56.87% -5.34% 0.85% 4.17% 16.05% 8.69% -4.93% -2.95% -12.55% -9.36% 16.82%  
  cost of revenue47,368,000 45,117,000 44,365,000 44,972,000 44,537,000 42,381,000 45,276,000 44,843,000 47,281,000 47,357,000 54,717,000 59,560,000 60,065,000 77,725,000 62,134,000 43,466,000 35,858,000 74,075,000 51,772,000 26,261,000 7,717,000 4,057,000 3,634,000 3,885,000 3,620,000 2,968,000 2,769,000 2,612,000 2,544,000 2,772,000 2,545,000 2,268,000 1,879,000 1,859,000 1,864,000 2,143,000 
  gross profit34,435,000 28,346,000 31,849,000 26,771,000 26,491,000 22,104,000 25,229,000 39,844,000 20,572,000 18,811,000 12,987,000 46,095,000 65,276,000 242,543,000 189,537,000 184,402,000 117,758,000 285,354,000 243,206,000 75,455,000 9,548,000 3,696,000 4,753,000 6,462,000 4,804,000 2,402,000 2,904,000 3,013,000 2,856,000 1,881,000 1,736,000 2,235,000 2,761,000 3,447,000 3,990,000 2,868,000 
  yoy29.99% 28.24% 26.24% -32.81% 28.77% 17.51% 94.26% -13.56% -68.48% -92.24% -93.15% -75.00% -44.57% -15.00% -22.07% 144.39% 1133.33% 7620.62% 5016.89% 1067.67% 98.75% 53.87% 63.67% 114.47% 68.21% 27.70% 67.28% 34.81% 3.44% -45.43% -56.49% -22.07%     
  qoq21.48% -11.00% 18.97% 1.06% 19.85% -12.39% -36.68% 93.68% 9.36% 44.84% -71.83% -29.38% -73.09% 27.97% 2.78% 56.59% -58.73% 17.33% 222.32% 690.27% 158.33% -22.24% -26.45% 34.51% 100.00% -17.29% -3.62% 5.50% 51.83% 8.35% -22.33% -19.05% -19.90% -13.61% 39.12%  
  gross margin %42.10% 38.59% 41.79% 37.32% 37.30% 34.28% 35.78% 47.05% 30.32% 28.43% 19.18% 43.63% 52.08% 75.73% 75.31% 80.92% 76.66% 79.39% 82.45% 74.18% 55.30% 47.67% 56.67% 62.45% 57.03% 44.73% 51.19% 53.56% 52.89% 40.43% 40.55% 49.63% 59.50% 64.96% 68.16% 57.23% 
  operating expenses                                    
  research and development13,480,000 12,395,000 12,113,000 11,783,000 13,486,000 11,434,000 11,952,000 10,014,000 9,692,000 9,782,000 8,509,000 7,507,000 6,905,000 5,989,000 7,464,000 6,021,000 5,312,000 5,422,000 4,576,000 3,177,000 1,849,000 1,978,000 1,795,000 1,744,000 1,574,000 1,424,000 1,426,000 1,438,000 1,212,000 1,458,000 1,324,000 1,128,000 920,000 851,000 819,000 1,523,000 
  selling and marketing12,286,000 8,465,000 9,538,000 9,124,000 8,595,000 8,989,000 10,500,000 10,161,000 10,723,000 10,083,000 10,253,000 9,859,000 10,866,000 7,940,000 8,200,000 6,012,000 5,219,000 5,008,000 5,081,000 5,014,000 3,260,000 1,597,000 1,635,000 1,687,000 1,304,000 1,272,000 1,128,000 1,115,000 1,279,000 1,130,000 1,080,000 1,383,000 851,000 891,000 798,000 893,000 
  general and administrative26,392,000 25,291,000 24,341,000 20,950,000 21,326,000 21,489,000 31,706,000 17,498,000 17,993,000 21,802,000 28,793,000 26,266,000 30,240,000 25,775,000 22,102,000 12,299,000 8,329,000 8,002,000 7,640,000 3,741,000 1,799,000 2,035,000 1,732,000 1,522,000 1,631,000 1,529,000 1,379,000 1,306,000 1,366,000 1,487,000 1,402,000 1,205,000 1,140,000 1,486,000 1,115,000 1,147,000 
  amortization of intangible assets1,990,000 1,990,000 1,992,000 1,993,000 1,990,000 1,990,000 1,958,000 1,957,000 1,962,000 1,968,000 2,010,000 2,006,000 1,575,000 906,000                       
  total operating expenses54,148,000 48,141,000 47,984,000 43,850,000 45,397,000 43,902,000 176,350,000 39,630,000 40,370,000 43,635,000 49,539,000 45,743,000 52,482,000 40,610,000 38,677,000 25,129,000 18,860,000 18,432,000 17,297,000 11,932,000 6,908,000 5,610,000 5,162,000 4,953,000 4,509,000 4,225,000 3,933,000 3,859,000 3,857,000 4,075,000 3,806,000 3,716,000 2,911,000 3,228,000 2,732,000 3,563,000 
  operating income-19,713,000 -19,795,000 -16,135,000 -17,079,000 -18,906,000 -21,798,000 -151,121,000 214,000 -19,798,000 -24,824,000 -36,552,000 352,000 12,794,000 201,933,000 150,860,000 159,273,000 98,898,000 266,922,000 225,909,000 63,523,000 2,640,000 -1,914,000 -409,000 1,509,000 295,000 -1,823,000 -1,029,000 -846,000 -1,001,000 -2,194,000 -2,070,000 -1,481,000 -150,000 219,000 1,258,000 -695,000 
  yoy4.27% -9.19% -89.32% -8080.84% -4.51% -12.19% 313.44% -39.20% -254.74% -112.29% -124.23% -99.78% -87.06% -24.35% -33.22% 150.73% 3646.14% -14045.77% -55334.47% 4109.61% 794.92% 4.99% -60.25% -278.37% -129.47% -16.91% -50.29% -42.88% 567.33% -1101.83% -264.55% 113.09%     
  qoq-0.41% 22.68% -5.53% -9.66% -13.27% -85.58% -70717.29% -101.08% -20.25% -32.09% -10484.09% -97.25% -93.66% 33.85% -5.28% 61.05% -62.95% 18.15% 255.63% 2306.17% -237.93% 367.97% -127.10% 411.53% -116.18% 77.16% 21.63% -15.48% -54.38% 5.99% 39.77% 887.33% -168.49% -82.59% -281.01%  
  operating margin %-24.10% -26.95% -21.17% -23.81% -26.62% -33.80% -214.34% 0.25% -29.18% -37.52% -53.99% 0.33% 10.21% 63.05% 59.94% 69.90% 64.38% 74.26% 76.59% 62.45% 15.29% -24.69% -4.88% 14.58% 3.50% -33.95% -18.14% -15.04% -18.54% -47.15% -48.35% -32.89% -3.23% 4.13% 21.49% -13.87% 
  other income46,000 68,000 7,000 544,000                                 
  interest income8,091,000 8,018,000 8,123,000 8,090,000                                 
  interest expense-17,000 -14,000 -40,000 -14,000                                 
  impairment loss-9,926,000                                    
  total other income-1,806,000 8,072,000 8,090,000 -1,453,000                                 
  income before income taxes-21,519,000 -11,723,000 -8,045,000 -18,532,000 -11,214,000 -14,173,000 -7,222,250 6,860,000 -14,700,000 -21,049,000    201,978,000                    338,000 1,316,000 -690,000 
  benefit from income taxes-2,263,000 176,000   -2,124,000 -327,000 -10,862,000 20,326,000   -9,386,000 414,000 2,653,000 48,421,000 47,148,000 37,545,000 23,589,000 66,513,000 58,571,000 14,526,000 -599,000 34,000 -38,000 61,000 7,000 13,000 888,000 -318,000 -100,000 -434,000 -596,000 -415,000 -110,000 106,000 503,000 417,000 
  net income from consolidated operations-19,256,000 -11,899,000 -6,190,000 -14,694,000 -9,090,000 -13,846,000 -134,334,000 -13,466,000 -11,590,000 -15,849,000 -24,076,000 1,343,000 11,099,000 153,557,000 103,677,000 122,224,000 79,647,000                    
  net income attributable to noncontrolling interests299,000 369,000 302,000 46,000 380,000 384,000 6,185,000 359,000 361,000 509,000 244,000 376,000 438,000 422,000 662,000 298,000 165,000                    
  net income attributable to fulgent-18,957,000 -11,530,000 -5,888,000 -14,648,000 -8,710,000 -13,462,000 -128,149,000 -13,107,000 -11,229,000 -15,340,000 -23,832,000 1,719,000 11,537,000 153,979,000 104,339,000 122,522,000 79,812,000                    
  net income per common share attributable to fulgent                                    
  basic-620 -370 -190 -480 -290 -450 -4,300 -440 -380 -520 -770 60 380 5,090 3,460 4,130 2,740 6,960 7,240 2,110 150 -90 -10 80 20 -100 -50 -30 -60 -110       
  diluted-620 -370 -190 -480 -290 -450 -4,300 -440 -380 -520 -750 60 370 4,930 3,340 3,930 2,590 6,520 6,840 1,980 140 -90 -10 80 20 -100 -50 -30 -60 -110       
  weighted-average common shares:                                    
  basic30,544,000 30,832,000 30,235,000 30,416,000 30,098,000 29,769,000 29,784,000 30,013,000 29,813,000 29,536,000 30,097,000 30,174,000 30,362,000 30,234,000 29,408,000 29,673,000 29,150,000 28,831,000 22,694,000 22,062,000 21,747,000 21,566,000 18,709,000 18,501,000 18,343,000 18,228,000  18,012,000 17,919,000 17,864,000  17,752,000 17,711,000 17,676,000   
  diluted30,544,000 30,832,000 30,235,000 30,416,000 30,098,000 29,769,000 29,784,000 30,013,000 29,813,000 29,536,000 30,964,000 30,867,000 31,189,000 31,240,000 30,976,000 31,170,000 30,830,000 30,770,000 24,056,000 23,539,000 22,920,000 21,566,000 18,709,000 19,456,000 19,021,000 18,228,000  18,012,000 17,919,000 17,864,000  17,752,000 17,711,000 18,178,000   
  operating expenses:                                    
  impairment of available-for-sale debt securities   -10,073,000                                 
  (benefit from) benefit from income taxes  -1,855,000 -3,838,000     -3,110,000 -5,200,000                           
  interest and other income    7,692,000 7,625,000 5,925,000 6,646,000 5,098,000 3,775,000 3,090,000 1,405,000 958,000 45,000 -35,000 496,000 604,000 282,000 589,000 421,000 275,000 241,000 249,000 189,000 192,000 207,000 98,000 143,000 98,000 95,000 97,000 145,000 120,000 119,000 58,000 5,000 
  net income per common share attributable to fulgent:                                    
  basic-620 -370 -190 -480 -290 -450 -4,300 -440 -380 -520 -770 60 380 5,090 3,460 4,130 2,740 6,960 7,240 2,110 150 -90 -10 80 20 -100 -50 -30 -60 -110       
  diluted-620 -370 -190 -480 -290 -450 -4,300 -440 -380 -520 -750 60 370 4,930 3,340 3,930 2,590 6,520 6,840 1,980 140 -90 -10 80 20 -100 -50 -30 -60 -110       
  restructuring costs          -26,000 105,000 2,896,000                        
  income before income taxes and gain on equity method investment          54,371,750 1,757,000 13,752,000                        
  income before gain on equity method investment          41,499,750 1,343,000 11,099,000                        
  gain on equity method investment                3,734,000                    
  amortization of acquisition-related intangible assets              199,250 797,000                     
  income before income taxes, gain on equity method investments and equity loss in investee              131,618,750 159,769,000                     
  income before gain on equity method investments and equity loss in investee              99,707,000 122,224,000                     
  gain on equity-method investments                                    
  equity loss in investee                  143,000 -189,000 -193,000 -249,000 -174,000 -175,000 -149,000 -279,000 -234,000 -210,000 -246,000 -245,000 -247,000 -172,000     
  income before income taxes, gain on equity method investment and equity loss in investee                99,502,000                    
  income before gain on equity method investment and equity loss in investee                75,913,000                    
  income before income taxes and equity loss in investee                 267,204,000   2,915,000 -1,673,000 -160,000 1,698,000 487,000 -1,616,000 -931,000 -703,000 -903,000 -2,099,000 -1,973,000 -1,336,000     
  income before equity loss in investee                 200,691,000   3,514,000 -1,707,000 -122,000 1,637,000 480,000 -1,629,000 -1,819,000 -385,000 -803,000 -1,665,000 -1,377,000 -921,000     
  net income                 200,691,000 166,307,000 46,638,000 3,321,000 -1,956,000 -296,000 1,462,000 331,000 -1,908,000 -2,053,000 -595,000 -1,049,000 -1,910,000 -1,624,000 -1,093,000 -25,000 232,000 813,000 -1,107,000 
  yoy                 -10360.28% -56284.80% 3090.01% 903.32% 2.52% -85.58% -345.71% -131.55% -0.10% 26.42% -45.56% 4096.00% -923.28% -299.75% -1.26%     
  qoq                 20.68% 256.59% 1304.34% -269.79% 560.81% -120.25% 341.69% -117.35% -7.06% 245.04% -43.28% -45.08% 17.61% 48.58% 4272.00% -110.78% -71.46% -173.44%  
  net income margin %0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 55.84% 56.38% 45.85% 19.24% -25.23% -3.53% 14.13% 3.93% -35.53% -36.19% -10.58% -19.43% -41.05% -37.94% -24.27% -0.54% 4.37% 13.89% -22.09% 
  net income per common share:                                    
  basic-620 -370 -190 -480 -290 -450 -4,300 -440 -380 -520 -770 60 380 5,090 3,460 4,130 2,740 6,960 7,240 2,110 150 -90 -10 80 20 -100 -50 -30 -60 -110       
  diluted-620 -370 -190 -480 -290 -450 -4,300 -440 -380 -520 -750 60 370 4,930 3,340 3,930 2,590 6,520 6,840 1,980 140 -90 -10 80 20 -100 -50 -30 -60 -110       
  income before income taxes, equity loss in investee and impairment loss                  226,498,000 63,944,000                 
  income before equity loss in investee and impairment loss                  167,927,000 49,418,000                 
  impairment loss in equity-method investment                  -647,750 -2,591,000                 
  income from continuing operations                              -1,624,000 -1,093,000 -25,000 232,000 813,000 -1,107,000 
  income from discontinued operations                                    
  continuing operations:                                    
  income per common share:                                    
  basic                              -12.5 -60 10   
  diluted                              -12.5 -60 10   
  income before income taxes and equity in net income of affiliate                                -30,000    
  income before equity in net income of affiliate                                80,000    
  equity in net income of affiliate                                -105,000    
  basic and diluted income per common share:                                    
  continuing operations—common stock                                  170 -440 
  weighted-average common shares—outstanding—basic and diluted                                  13,710,000 12,846,000 

We provide you with 20 years income statements for Fulgent Genetics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Fulgent Genetics stock. Explore the full financial landscape of Fulgent Genetics stock with our expertly curated income statements.

The information provided in this report about Fulgent Genetics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.